FLUDEOXYGLUCOSE F-18
NDC 24450-647, FLUDEOXYGLUCOSE F-18, injection, from BRIGHAM AND WOMEN`S HOSPITAL, INC., THE.
- Product NDC
- 24450-647
- Status
- Listed
- Labeler
- BRIGHAM AND WOMEN`S HOSPITAL, INC., THE
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA203816
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/24450-647 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FLUDEOXYGLUCOSE F-18300 mCi/mL
Pharmacologic classes
Radioactive Diagnostic Agent [EPC]; Radiopharmaceutical Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 24450-647-30 | 24450064730 | 30 mL in 1 VIAL, MULTI-DOSE (24450-647-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/6b7b71c9-f10c-4ace-8166-ea242d8e628d
Use it
Look up 24450-647 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/24450-647 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 24450-647. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.